Braveheart Bio, Inc. (BRVE) Income Statement
BRVE 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsBRVE revenue and net income
BRVE growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BRVE quarterly EPS vs estimates
Braveheart Bio beat the analyst EPS estimate in 0 of the last 1 quarters. Next report: December 8, 2026 (estimate $-0.91).
BRVE income statement
| 2025 | |
|---|---|
| Revenue | $0 |
| Research & development | $1.5M |
| Sales, general & admin | $3.0M |
| Total operating expenses | $4.5M |
| Operating income | −$4.5M |
| Interest income | $696,000 |
| Income before taxes | −$66.1M |
| Net income | −$66.1M |
| EBITDA | −$4.5M |
| Jun '26 | Mar '26 | Jun '25 | Mar '25 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $11.1M | $10.9M | $0 | $0 |
| Sales, general & admin | $4.8M | $4.1M | $27,000 | $5,000 |
| Total operating expenses | $15.9M | $15.0M | $27,000 | $5,000 |
| Operating income | −$15.9M | −$15.0M | −$27,000 | −$5,000 |
| Interest income | $889,000 | $771,000 | $0 | $0 |
| Income before taxes | −$15.0M | −$14.3M | −$381,000 | −$99,000 |
| Net income | −$15.0M | −$14.3M | −$381,000 | −$99,000 |
| EBITDA | −$15.9M | −$15.0M | −$27,000 | −$5,000 |
| EPS (diluted) | −$2.51 | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BRVE's financial statements (latest annual report filed —); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BRVE financial results
Braveheart Bio reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $66.1 million.
See the BRVE stock overview for the latest quote and news, or the BRVE chart for price history and technical indicators.
BRVE income statement FAQ
Does Braveheart Bio have revenue?
Braveheart Bio reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is Braveheart Bio profitable?
No. Braveheart Bio reported a net loss of $66.1 million in fiscal 2025.
How much does Braveheart Bio spend on research and development?
Braveheart Bio spent $1.5 million on research and development in fiscal 2025.
When will Braveheart Bio report its next earnings?
Braveheart Bio is expected to report results for the quarter ending September 30, 2026 on December 8, 2026.
When does Braveheart Bio's fiscal year end?
Braveheart Bio's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025.